Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity

Free Radical Biology and Medicine

Volumn 45, Issue 7, 2008, Pages 1019-1026

  Chao, Jianfei ^a,b   Yu, Man Shan ^b   Ho, Yuen Shan ^b   Wang, Mingfu ^a   Chang, Raymond Chuen Chung ^b,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

6 Hydroxydopamine; Free radicals; Neuroprotection; Oxyresveratrol; Parkinson disease; Resveratrol

Indexed keywords

CASPASE 3; CELL EXTRACT; LACTATE DEHYDROGENASE; OXIDOPAMINE; OXYRESVERATROL; PROTEIN C JUN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SIRTUIN 1; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG SOLUBILITY; ENZYME RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ADRENERGIC AGENTS; ANTIOXIDANTS; BLOTTING, WESTERN; CASPASE 3; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; L-LACTATE DEHYDROGENASE; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; OXIDOPAMINE; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES; STILBENES;

MORUS (PLANT); PARKINSONIA;

EID: 51549098145     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.07.002     Document Type: Article

References (77)

1. Dauer W., and Przedborski S. Parkinson's disease: mechanisms and models. Neuron 39 (2003) 889-909
2. Weiner W.J. Initial treatment of Parkinson disease: levodopa or dopamine agonists. Arch. Neurol. 61 (2004) 1966-1969
3. Bychkov E., Ahmed M.R., Dalby K.N., and Gurevich E.V. Dopamine depletion and subsequent treatment with L-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum. J. Neurochem. 102 (2007) 699-711
4. McGeer P.L., and McGeer E.G. Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat. Disord. 10 (2004) S3-S7
5. Yamamoto N., Sawada H., Izumi Y., Kume T., Katsuki H., Shimohama S., and Akaike A. Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress: relevance to Parkinson disease. J. Biol. Chem. 282 (2007) 4364-4372
6. Anderson C., Checkoway H., Franklin G.M., Beresford S., Smith-Weller T., and Swanson P.D. Dietary factors in Parkinson's disease: the role of food groups and specific foods. Mov. Disord. 14 (1999) 21-27
7. de Lau L.M., Koudstaal P.J., Witteman J.C., Hofman A., and Breteler M.M. Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease. Neurology 67 (2006) 315-318
8. Gao X., Chen H., Fung T.T., Logroscino G., Schwarzschild M.A., Hu F.B., and Ascherio A. Prospective study of dietary pattern and risk of Parkinson disease. Am. J. Clin. Nutr. 86 (2007) 1486-1494
9. Chalimoniuk M., Stepien A., and Strosznajder J.B. Pergolide mesylate, a dopaminergic receptor agonist, applied with L-DOPA enhances serum antioxidant enzyme activity in Parkinson disease. Clin. Neuropharmacol. 27 (2004) 223-229
10. Willis L., Bickford P., Zaman V., Moore A., and Granholm A.C. Blueberry extract enhances survival of intraocular hippocampal transplants. Cell Transplant. 14 (2005) 213-223
11. Kanaan N.M., Collier T.J., Marchionini D.M., McGuire S.O., Fleming M.F., and Sortwell C.E. Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease. Brain Res. 1068 (2006) 221-229
12. McGuire S.O., Sortwell C.E., Shukitt-Hale B., Joseph J.A., Hejna M.J., and Collier T.J. Dietary supplementation with blueberry extract improves survival of transplanted dopamine neurons. Nutr. Neurosci. 9 (2006) 251-258
13. Auger C., Teissedre P.L., Gerain P., Lequeux N., Bornet A., Serisier S., Besancon P., Caporiccio B., Cristol J.P., and Rouanet J.M. Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation. J. Agric. Food Chem. 53 (2005) 2015-2021
14. Ramassamy C. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur. J. Pharmacol. 545 (2006) 51-64
15. Sengottuvelan M., and Nalini N. Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-dimethylhydrazine-treated rats by modulating biotransforming enzymes and aberrant crypt foci development. Br. J. Nutr. 96 (2006) 145-153
16. Shin N.H., Ryu S.Y., Choi E.J., Kang S.H., Chang I.M., Min K.R., and Kim Y. Oxyresveratrol as the potent inhibitor on dopa oxidase activity of mushroom tyrosinase. Biochem. Biophys. Res. Commun. 243 (1998) 801-803
17. Kim Y.M., Yun J., Lee C.K., Lee H., Min K.R., and Kim Y. Oxyresveratrol and hydroxystilbene compounds: inhibitory effect on tyrosinase and mechanism of action. J. Biol. Chem. 277 (2002) 16340-16344
18. Likhitwitayawuid K., Chaiwiriya S., Sritularak B., and Lipipun V. Antiherpetic flavones from the heartwood of Artocarpus gomezianus. Chem. Biodivers. 3 (2006) 1138-1143
19. Oh H., Ko E.K., Jun J.Y., Oh M.H., Park S.U., Kang K.H., Lee H.S., and Kim Y.C. Hepatoprotective and free radical scavenging activities of prenylflavonoids, coumarin, and stilbene from Morus alba. Planta Med. 68 (2002) 932-934
20. Su B.N., Cuendet M., Hawthorne M.E., Kardono L.B., Riswan S., Fong H.H., Mehta R.G., Pezzuto J.M., and Kinghorn A.D. Constituents of the bark and twigs of Artocarpus dadah with cyclooxygenase inhibitory activity. J. Nat. Prod. 65 (2002) 163-169
21. Mouihate A., Horn T.F., and Pittman Q.J. Oxyresveratrol dampens neuroimmune responses in vivo: a selective effect on TNF-alpha. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 (2006) R1215-1221
22. Andrabi S.A., Spina M.G., Lorenz P., Ebmeyer U., Wolf G., and Horn T.F. Oxyresveratrol (trans-2,3′,4,5′-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia. Brain Res. 1017 (2004) 98-107
23. Ban J.Y., Jeon S.Y., Nguyen T.T., Bae K., Song K.S., and Seong Y.H. Neuroprotective effect of oxyresveratrol from Smilacis chinae rhizome on amyloid beta protein (25-35)-induced neurotoxicity in cultured rat cortical neurons. Biol. Pharm. Bull. 29 (2006) 2419-2424
24. Jeon S.Y., Kwon S.H., Seong Y.H., Bae K., Hur J.M., Lee Y.Y., Suh D.Y., and Song K.S. Beta-secretase (BACE1)-inhibiting stilbenoids from smilax rhizoma. Phytomedicine 14 (2007) 403-408
25. Lorenz P., Roychowdhury S., Engelmann M., Wolf G., and Horn T.F. Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: effect on nitrosative and oxidative stress derived from microglial cells. Nitric Oxide 9 (2003) 64-76
26. Qiu F., Komatsu K., Saito K., Kawasaki K., Yao X., and Kano Y. Pharmacological properties of traditional medicines. XXII. Pharmacokinetic study of mulberroside A and its metabolites in rat. Biol. Pharm. Bull. 19 (1996) 1463-1467
27. Breuer C., Wolf G., Andrabi S.A., Lorenz P., and Horn T.F. Blood-brain barrier permeability to the neuroprotectant oxyresveratrol. Neurosci. Lett. 393 (2006) 113-118
28. Li H., Cheng K.W., Cho C.H., He Z., and Wang M. Oxyresveratrol as an antibrowning agent for cloudy apple juices and fresh-cut apples. J. Agric. Food Chem. 55 (2007) 2604-2610
29. Yu M.S., Lai S.W., Lin K.F., Fang J.N., Yuen W.H., and Chang R.C.C. Characterization of polysaccharides from the flowers of Nerium indicum and their neuroprotective effects. Int. J. Mol. Med. 14 (2004) 917-924
30. Lai S.W., Yu M.S., Yuen W.H., and Chang R.C.C. Novel neuroprotective effects of the aqueous extracts from Verbena officinalis Linn. Neuropharmacology 50 (2006) 641-650
31. Ho Y.S., Yu M.S., Lai C.S., So K.F., Yuen W.H., and Chang R.C.C. Characterizing the neuroprotective effects of alkaline extract of Lycium barbarum on beta-amyloid peptide neurotoxicity. Brain Res. 1158 (2007) 123-134
32. Yu M.S., Lai C.S., Ho Y.S., Zee S.Y., So K.F., Yuen W.H., and Chang R.C.C. Characterization of the effects of anti-aging medicine Fructus lycii on beta-amyloid peptide neurotoxicity. Int. J. Mol. Med. 20 (2007) 261-268
33. Lai C.S.W., Yu M.S., Yuen W.H., So K.F., Zee S.Y., and Chang R.C.C. Antagonizing [beta]-amyloid peptide neurotoxicity of the anti-aging fungus Ganoderma lucidum. Brain Res. 1190 (2008) 215-224
34. Chang R.C.C., Suen K.C., Ma C.H., Elyaman W., Ng H.K., and Hugon J. Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2 alpha in neuronal degeneration. J. Neurochem. 83 (2002) 1215-1225
35. Suen K.C., Lin K.F., Elyaman W., So K.F., Chang R.C.C., and Hugon J. Reduction of calcium release from the endoplasmic reticulum could only provide partial neuroprotection against beta-amyloid peptide toxicity. J. Neurochem. 87 (2003) 1413-1426
36. Suen K.C., Yu M.S., So K.F., Chang R.C.C., and Hugon J. Upstream signaling pathways leading to the activation of double-stranded RNA-dependent serine/threonine protein kinase in beta-amyloid peptide neurotoxicity. J. Biol. Chem. 278 (2003) 49819-49827
37. Lin K.F., Chang R.C.C., Suen K.C., So K.F., and Hugon J. Modulation of calcium/calmodulin kinase-II provides partial neuroprotection against beta-amyloid peptide toxicity. Eur. J. Neurosci. 19 (2004) 2047-2055
38. Yu M.S., Leung S.K., Lai S.W., Che C.M., Zee S.Y., So K.F., Yuen W.H., and Chang R.C.C. Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against beta-amyloid peptide neurotoxicity. Exp. Gerontol. 40 (2005) 716-727
39. Yu M.S., Suen K.C., Kwok N.S., So K.F., Hugon J., and Chang R.C.C. Beta-amyloid peptides induces neuronal apoptosis via a mechanism independent of unfolded protein responses. Apoptosis 11 (2006) 687-700
40. Lee H.H., Lin C.T., and Yang L.L. Neuroprotection and free radical scavenging effects of Osmanthus fragrans. J. Biomed. Sci. 14 (2007) 819-827
41. Xu B.J., Yuan S.H., and Chang S.K.C. Comparative analyses of phenolic composition, antioxidant capacity, and color of cool season legumes and other selected food legumes. J. Food Sci. 72 (2007) S167-S177
42. Vrablic A.S., Albright C.D., Craciunescu C.N., Salganik R.I., and Zeisel S.H. Altered mitochondrial function and overgeneration of reactive oxygen species precede the induction of apoptosis by 1-O-octadecyl-2-methyl-rac-glycero-3-phosphocholine in p53-defective hepatocytes. FASEB J. 15 (2001) 1739-1744
43. Fang X., Yu M.M., Yuen W.H., Zee S.Y., and Chang R.C.C. Immune modulatory effects of Prunella vulgaris L. on monocytes/macrophages. Int. J. Mol. Med. 16 (2005) 1109-1116
44. Yu M.S., Ho Y.S., So K.F., Yuen W.H., and Chang R.C.C. Cytoprotective effects of Lycium barbarum against reducing stress on endoplasmic reticulum. Int. J. Mol. Med. 17 (2006) 1157-1161
45. +-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. J. Neurosci. Res. 57 (1999) 86-94
46. Borsello T., and Forloni G. JNK signalling: a possible target to prevent neurodegeneration. Curr. Pharm. Des. 13 (2007) 1875-1886
47. Choi W.S., Eom D.S., Han B.S., Kim W.K., Han B.H., Choi E.J., Oh T.H., Markelonis G.J., Cho J.W., and Oh Y.J. Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons. J. Biol. Chem. 279 (2004) 20451-20460
48. Fujita H., Ogino T., Kobuchi H., Fujiwara T., Yano H., Akiyama J., Utsumi K., and Sasaki J. Cell-permeable cAMP analog suppresses 6-hydroxydopamine-induced apoptosis in PC12 cells through the activation of the Akt pathway. Brain Res. 1113 (2006) 10-23
49. Araki T., Sasaki Y., and Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305 (2004) 1010-1013
50. Yeung F., Hoberg J.E., Ramsey C.S., Keller M.D., Jones D.R., Frye R.A., and Mayo M.W. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23 (2004) 2369-2380
51. Borra M.T., Smith B.C., and Denu J.M. Mechanism of human SIRT1 activation by resveratrol. J. Biol. Chem. 280 (2005) 17187-17195
52. Mecocci P., Cherubini A., Polidori M.C., Cecchetti R., Chionne F., and Senin U. Oxidative stress and dementia: new perspectives in AD pathogenesis. Aging (Milano) 9 (1997) 51-52
53. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59 (1992) 1609-1623
54. Jenner P. Oxidative stress in Parkinson's disease and other neurodegenerative disorders. Pathol. Biol. (Paris) 44 (1996) 57-64
55. Sayre L.M., Smith M.A., and Perry G. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 8 (2001) 721-738
56. Cherubini A., Ruggiero C., Polidori M.C., and Mecocci P. Potential markers of oxidative stress in stroke. Free Radic. Biol. Med. 39 (2005) 841-852
57. Glinka Y., Gassen M., and Youdim M.B. Mechanism of 6-hydroxydopamine neurotoxicity. J. Neural Transm. Suppl. 50 (1997) 55-66
58. Cerruti C., Drian M.J., Kamenka J.M., and Privat A. Protection by BTCP of cultured dopaminergic neurons exposed to neurotoxins. Brain Res. 617 (1993) 138-142
59. Soleas G.J., Diamandis E.P., and Goldberg D.M. Wine as a biological fluid: history, production, and role in disease prevention. J. Clin. Lab. Anal. 11 (1997) 287-313
60. Das D.K., Sato M., Ray P.S., Maulik G., Engelman R.M., Bertelli A.A.E., and Bertelli A. Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp. Clin. Res. 25 (1999) 115-120
61. Alvira D., Yeste-Velasco M., Folch J., Verdaguer E., Canudas A.M., Pallas M., and Camins A. Comparative analysis of the effects of resveratrol in two apoptotic models: inhibition of complex I and potassium deprivation in cerebellar neurons. Neuroscience 147 (2007) 746-756
62. Anekonda T.S. Resveratrol-a boon for treating Alzheimer's disease?. Brain Res. Rev. 52 (2006) 316-326
63. Ates O., Cayli S., Altinoz E., Gurses I., Yucel N., Sener M., Kocak A., and Yologlu S. Neuroprotection by resveratrol against traumatic brain injury in rats. Mol. Cell. Biochem. 294 (2007) 137-144
64. Bastianetto S., and Quirion R. Natural extracts as possible protective agents of brain aging. Neurobiol. Aging 23 (2002) 891-897
65. Zamin L.L., Dillenburg-Pilla P., Argenta-Comiran R., Horn A.P., Simao F., Nassif M., Gerhardt D., Frozza R.L., and Salbego C. Protective effect of resveratrol against oxygen-glucose deprivation in organotypic hippocampal slice cultures: involvement of PI3-K pathway. Neurobiol. Dis. 24 (2006) 170-182
66. Williams R.J., Spencer J.P., and Rice-Evans C. Flavonoids: antioxidants or signalling molecules? Free Radic. Biol. Med. 36 (2004) 838-849
67. Agullo G., Gamet-Payrastre L., Manenti S., Viala C., Remesy C., Chap H., and Payrastre B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem. Pharmacol. 53 (1997) 1649-1657
68. Gamet-Payrastre L., Manenti S., Gratacap M.P., Tulliez J., Chap H., and Payrastre B. Flavonoids and the inhibition of PKC and PI 3-kinase. Gen. Pharmacol. 32 (1999) 279-286
69. Kang H.M., Kim J.H., Lee M.Y., Son K.H., Yang D.C., Baek N.I., and Kwon B.M. Relationship between flavonoid structure and inhibition of farnesyl protein transferase. Nat. Prod. Res. 18 (2004) 349-356
70. Rogina B., and Helfand S.L. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. USA 101 (2004) 15998-16003
71. Alcendor R.R., Gao S., Zhai P., Zablocki D., Holle E., Yu X., Tian B., Wagner T., Vatner S.F., and Sadoshima J. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res. 100 (2007) 1512-1521
72. Hsu C.P., Odewale I., Alcendor R.R., and Sadoshima J. Sirt1 protects the heart from aging and stress. Biol. Chem. 389 (2008) 221-231
73. Pallas M., Verdaguer E., Tajes M., Gutierrez-Cuesta J., and Camins A. Modulation of sirtuins: new targets for antiageing. Recent Pat. CNS Drug Discovery 3 (2008) 61-69
74. Kume S., Haneda M., Kanasaki K., Sugimoto T., Araki S., Isono M., Isshiki K., Uzu T., Kashiwagi A., and Koya D. Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation. Free Radic. Biol. Med. 40 (2006) 2175-2182
75. Kobayashi Y., Furukawa-Hibi Y., Chen C., Horio Y., Isobe K., Ikeda K., and Motoyama N. SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress. Int. J. Mol. Med. 16 (2005) 237-243
76. Wu A., Ying Z., and Gomez-Pinilla F. Oxidative stress modulates Sir2alpha in rat hippocampus and cerebral cortex. Eur. J. Neurosci. 23 (2006) 2573-2580
77. Wu A., Ying Z., and Gomez-Pinilla F. Omega-3 fatty acids supplementation restores mechanisms that maintain brain homeostasis in traumatic brain injury. J. Neurotrauma. 24 (2007) 1587-1595